What is Vyvanse?
Vyvanse (lisdexamfetamine dimesylate) is a prescription medicine used for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients 6 years and above, and for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults. Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective for the treatment of obesity.

IMPORTANT SAFETY INFORMATION

Vyvanse is a stimulant medicine. Tell the doctor if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Please see additional Important Safety Information below.

Eligibility Requirements
In order to redeem this offer, you must have a valid prescription for Vyvanse. Follow the dosage instructions given by the prescribing doctor. This offer may not be redeemed for cash. By using this offer, you are certifying that you meet the eligibility criteria and will comply with the terms and conditions below. Patients with questions about this offer should call 1-866-441-3469.

Mobile Terms & Conditions
By agreeing to these Mobile Savings Program ("Program") text message terms and conditions, you agree to receive text messages on your mobile device subject to the Terms & Conditions described below. You understand that this consent is not a condition of purchase or use of VYVANSE or of any Takeda product or service.

• This Program is intended solely for US residents and is governed solely by US laws and government regulations
• Participants will receive an average of 5 text messages each month while enrolled in the Program
• There is no fee payable to Takeda to receive text messages; however, your carrier's message and data rates may apply
• Data obtained from you in connection with your registration for, and use of, this SMS service may include your phone number and/or email address, related carrier information, and elements of pharmacy claim information and will be used to administer this Program and to provide Program benefits such as information about your prescription, refill reminders, as well as Program updates and alerts
• Takeda will not be liable for any delays in the receipt of any SMS messages as delivery is subject to effective transmission from your network operator
• This Program is valid with most major US carriers, including: Verizon Wireless, Sprint, Nextel, Boost, T-Mobile^®, AT&T, Alltel, ACS Wireless, Bluegrass Cellular, Carolina West Wireless, CellCom, Cellular One of East Central Illinois (ECIT), Cincinnati Bell, Cricket, CSpire Wireless, Duet IP (AKA Max/Benton/Albany), Element Mobile, Epic Touch, GCI Communications, Golden State, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Valley Cellular (IVC), Inland Cellular, iWireless, Keystone Wireless (Immix/PC Management), MetroPCS, MobiPCS, Mosaic, MTPCS/Cellular One (Cellone Nation), Nex-Tech Wireless, nTelos, Panhandle Telecommunications, Pioneer, Plateau, Revol Wireless, Rina-Custer, Rina-All West, Rina-Cambridge Telecom Coop, Rina-Eagle Valley Comm, Rina-Farmers Mutual Telephone Co, Rina-Nucla Nutria Telephone Co, Rina-Silver Star, Rina-South Central Comm, Rina-Syringa, Rina-UBET, Rina-Manti, Simmetry, South Canaan/CellularOne of NEPA, Thumb Cellular, Union Wireless, United Wireless, U.S. Cellular, Viaero Wireless, Virgin Mobile, West Central Wireless (includes Five Star Wireless). (Names of listed service provider/carriers are trademarks or registered trademarks of their respective companies and owners)
• For T-Mobile customers, T-Mobile is NOT liable for delayed or undelivered messages
• Takeda may be required to contact the user if an adverse event is reported
• Takeda reserves the right to rescind, revoke, or amend the Program without notice at any time
• The information communicated through this Program is not intended to make a diagnosis or to take the place of talking to a US healthcare professional
• While Takeda makes reasonable efforts to include and transmit accurate, up-to-date information for this Program, Takeda makes no warranties or representations as to its accuracy. Takeda assumes no liability for any errors or omissions in the content transmitted through this Program
• In addition to the data use practices described in the Privacy Policy, we may send you offer-related push notifications. Your device's location will not be known or tracked by Takeda or its service providers. Nonetheless, you may opt out of receiving these notifications at any time by (1) disabling notifications (i.e., automatic updates) within the digital wallet app, or (2) removing the eCard from your digital wallet by selecting "Remove Pass" within the digital wallet app
• You can unsubscribe from the Program by texting STOP to 36395. For questions about this Program, text HELP to 36395

Terms & Conditions
Eligible patients will pay a minimum of $30 and receive up to a maximum of $60 off their co-pay or out-of-pocket expense on each prescription. Patient is responsible for the first $30 and any prescription costs in excess of $90. This offer can be used for up to 30 capsules or 30 chewable tablets of Vyvanse (lisdexamfetamine dimesylate). Offer is valid for up to 60 uses through offer expiry. A valid Prescriber ID# is required on each prescription.
Patient Instructions: In order to redeem this offer, you must have a valid prescription for Vyvanse. Follow the dosage instructions given by the prescribing doctor. This offer may not be redeemed for cash. By using this offer, you are certifying that you meet the eligibility criteria and will comply with the terms and conditions set forth in the “Restrictions” section below. Patients with questions about this offer should call 1-866-441-3469.
Pharmacist: When you apply this offer, you are certifying that you are not submitting the claim for this prescription for reimbursement under any federal, state, or other governmental programs. Participation in this offer must comply with all applicable laws and regulations as a pharmacy provider. By participating in this offer, you are certifying that you will comply with the terms and conditions set forth in the “Restrictions” section below.
Pharmacist instructions for a patient paying with an Eligible Third Party Payer: Submit the claim to the primary Third Party Payer first, then submit the balance due to CHANGE HEALTHCARE as a Secondary Payer COB [coordination of benefits] with patient responsibility amount and a valid Other Coverage Code, (e.g. 8). The patient is responsible for the first $30 and the offer pays up to the next $60. Reimbursement will be received from CHANGE HEALTHCARE.
Pharmacist instructions for a cash paying patient: Submit this claim to CHANGE HEALTHCARE. A valid Other Coverage Code (e.g. 1) is required. The patient is responsible for the first $30 and the card pays up to the next $60. Reimbursement will be received from CHANGE HEALTHCARE.
Valid Other Coverage Code required.
For any questions regarding CHANGE HEALTHCARE online processing, please call the Help Desk at 1-800-433-4893.
Restrictions: This offer is valid in the United States. Offer not valid for prescriptions covered by or submitted for reimbursement under Medicaid, a Medicare drug benefit plan, Tricare, or other federal or state health programs (including any state medical assistance program). Cash Discount Cards and other non-insurance plans are not valid as primary under this offer. If the patient is eligible for prescription drug benefits under any such program, the patient cannot use this offer. By using this offer, the patient certifies that he or she will comply with any terms of his or her health insurance contract requiring notification to his or her payer of the existence and/or value of this offer. It is illegal to (or offer to) sell, purchase, or trade this offer. This offer is not transferable and is limited to one offer per person. Offer expires 12/31/2024.
This offer is not valid if reproduced. Void where prohibited by law. Offer program managed by ConnectiveRx on behalf of Shire US Inc., a Takeda company, or its successor. The parties reserve the right to rescind, revoke, or amend this offer without notice at any time.

IMPORTANT SAFETY INFORMATION (continued)

Who should not take Vyvanse?
Do not take Vyvanse if you or your child are:

• taking or have taken an anti-depression medicine called a monoamine oxidase inhibitor (MAOI) within the past 14 days.
• sensitive or allergic to, or had a reaction to other stimulant medicines.

Serious problems can occur while taking Vyvanse. Tell the doctor:

• if you or your child have heart problems, heart defects, high blood pressure, or a family history of these problems. Sudden death has occurred in people with heart problems or defects taking stimulant medicines. Sudden death, stroke and heart attack have happened in adults taking stimulant medicines. Your doctor should check you or your child carefully for heart problems before starting Vyvanse. Since increases in blood pressure and heart rate may occur, the doctor should regularly check these during treatment. Call the doctor right away if you or your child have any signs of heart problems such as chest pain, shortness of breath, or fainting while taking Vyvanse.
• if you or your child have mental (psychiatric) problems, or a family history of suicide, bipolar illness, or depression. New or worse behavior and thought problems or new or worse bipolar illness may occur. New psychotic symptoms (such as seeing or hearing things that are not real, believing things that are not true, being suspicious) or new manic symptoms may occur. Call the doctor right away if there are any new or worsening mental symptoms or problems during treatment.
• if you or your child have circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud's phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color from pale, to blue, to red. Call the doctor right away if any signs of unexplained wounds appear on fingers or toes while taking Vyvanse.
• if your child is having slowing of growth (height or weight). The doctor should check your child's height and weight often while on Vyvanse, and may stop treatment if a problem is found.
• if you or your child have symptoms of serotonin syndrome: agitation, hallucinations, coma, or changes in mental status; problems controlling movements or muscle twitching, stiffness, or tightness; fast heartbeat; sweating or fever; nausea, vomiting or diarrhea. Call your doctor or go to the emergency room if symptoms occur. Serotonin syndrome may occur if Vyvanse is taken with certain medicines and may be life-threatening.
• if you or your child are pregnant or plan to become pregnant. It is not known if Vyvanse may harm your unborn baby.
• if you or your child are breastfeeding or plan to breastfeed. Do not breastfeed while taking Vyvanse. Talk to your doctor about the best way to feed your baby if you take Vyvanse.

What are possible side effects of Vyvanse?
The most common side effects of Vyvanse in ADHD include:

• anxiety
• dry mouth
• trouble sleeping
• decreased appetite
• irritability
• upper stomach pain
• diarrhea
• loss of appetite
• vomiting
• dizziness
• nausea
• weight loss

The most common side effects of Vyvanse in adults with moderate to severe
B.E.D. include:

• dry mouth
• constipation
• trouble sleeping
• feeling jittery
• decreased appetite
• anxiety
• increased heart rate

For additional safety information, click here for Prescribing Information and Medication Guide and discuss with your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

VYVANSE and the VYVANSE logo are registered trademarks of Shire LLC, a Takeda company. TAKEDA and the TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited. Copyright © 2019 Takeda Pharmaceutical Company Limited. All rights reserved. 1-800-828-2088.

S52528 11/19